Role of Ivabradine for Heart Rate Control in Management of Patients With Sepsis and Septic Shock

Summary

Tachycardia is associated with excess mortality during septic shock. This may be related to the increase in cardiac metabolic demand, impaired cardiac diastolic function and less effect of administered exogenous catecholamines. In this study, we evaluate the effect of enteral Ivabradine on outcome of septic patients regarding need for vasopressor therapy, mechanical ventilation, renal replacement therapy, length of ICU stay and in-hospital mortality.

Timeline

Start

2024-12-30

Primary completion

2025-06-30

Completion

2025-06-30

Drugs

Indications